11/29
12:31 am
femy
High
Report
11/20
08:43 am
femy
Femasys (NASDAQ:FEMY) is now covered by analysts at Laidlaw. They set a "buy" rating and a $6.50 price target on the stock.
Medium
Report
Femasys (NASDAQ:FEMY) is now covered by analysts at Laidlaw. They set a "buy" rating and a $6.50 price target on the stock.
11/14
05:41 pm
femy
Femasys GAAP EPS of -$0.10, revenue of $729M [Seeking Alpha]
Low
Report
Femasys GAAP EPS of -$0.10, revenue of $729M [Seeking Alpha]
11/14
05:27 pm
femy
Femasys Announces Third Quarter Financial Results for 2025 [Yahoo! Finance]
Low
Report
Femasys Announces Third Quarter Financial Results for 2025 [Yahoo! Finance]
11/14
04:01 pm
femy
Femasys Announces Third Quarter Financial Results for 2025
High
Report
Femasys Announces Third Quarter Financial Results for 2025
11/10
10:01 am
femy
Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe [Yahoo! Finance]
High
Report
Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe [Yahoo! Finance]
11/10
09:00 am
femy
Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe
High
Report
Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe
11/3
08:30 am
femy
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million
Medium
Report
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million
10/22
09:00 am
femy
Femasys Announces Initiation of Post-Market Surveillance Study for FemBloc® Permanent Birth Control in Europe
High
Report
Femasys Announces Initiation of Post-Market Surveillance Study for FemBloc® Permanent Birth Control in Europe
10/16
09:55 am
femy
Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo [Yahoo! Finance]
High
Report
Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo [Yahoo! Finance]
10/16
09:00 am
femy
Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo
High
Report
Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo
10/4
03:07 am
femy
High
Report
9/25
09:00 am
femy
Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership
Medium
Report
Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership
9/22
09:33 am
femy
Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed [Yahoo! Finance]
Low
Report
Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed [Yahoo! Finance]
9/22
09:00 am
femy
Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed
Medium
Report
Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed
9/11
09:31 am
femy
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed® [Yahoo! Finance]
Low
Report
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed® [Yahoo! Finance]
9/11
09:00 am
femy
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®
Low
Report
Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®
9/8
09:00 am
femy
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
Medium
Report
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand